California announces plan to produce $30 insulin
The product is not expected on store shelves until at least next year.
Stay updated with breaking news from Insulin Value. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The product is not expected on store shelves until at least next year.
Danish pharmaceutical company Novo Nordisk has announced it is lowering the U.S. list prices of several insulin products by up to 75% for people living with Type 1 and type 2 diabetes. It becomes the second drugmaker to do so, following Eli Lilly's announcement earlier this month that it was capping out-of-pocket costs to $35 a month for insulin. Novo Nordisk products include
This is a move that the company can afford to make.
The pharmaceutical giant is also expanding a program that caps insulin at $35.
Eli Lilly has announced that it is reducing the list price of its insulin by 70% and capping out-of-pocket costs at $35 a month as part of its Insulin Value Program. Effective immediately, Lilly will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin. Lilly is cutting the list price of its